Keywords: osi, acquires, oncology, assets, gilead, million, deal

OSI acquires oncology assets from Gilead in $200 million deal

Article | 27 November 2001

Print This

OSI Pharmaceuticals has signed an agreement, valued at up to $200million in cash and stock, by which it will acquire ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in